Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000303
Chunk: 100

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 100
---
 Section (4), immediately
due and payable in cash; provided that, in the case of any event with respect to the Company described in Section (2)(a)(ii), the full
unpaid Principal amount of this Note, together with interest and other amounts owing in respect thereof to the date of acceleration, shall
automatically become due and payable, in each case without presentment, demand, protest or other notice of any kind, all of which are
hereby waived by the Company. The Holder need not provide and the Company hereby waives any presentment, demand, protest or other notice
of any kind, and the Holder may immediately enforce any and all of its rights and remedies hereunder and all other remedies available
to it under applicable law. Such declaration may be rescinded and annulled by the Holder in writing at any time prior to payment hereunder.
No such rescission or annulment shall affect any subsequent Event of Default or impair any right consequent thereon. For the purposes
hereof, an Event of Default relating to default in payment is “continuing” if it has not been waived, and an Event
of Default relating to circumstances other than a default in payment is “continuing” if it has not been remedied or
waived.

(3) .

(a) . If this
Note is to be transferred, the Holder shall surrender this Note to the Company, whereupon the Company will forthwith issue and deliver
upon the order of the Holder a new Note (in accordance with Section (3)(d)), registered in the name of the registered transferee or assignee,
representing the outstanding Principal being transferred by the Holder (along with any accrued and unpaid interest thereof) and, if less
than the entire outstanding Principal is being transferred, a new Note (in accordance with Section (3)(d)) to the Holder representing
the outstanding Principal not being transferred.

(b) . Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of this Note, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary
form and, in the case of mutilation, upon surrender and cancellation of this Note, the Company shall execute and deliver to the Holder
a new Note (in accordance with Section (3)(d)) representing the outstanding Principal.

(c) . This Note is exchangeable, upon the surrender hereof by the Holder at the principal